Ocugen (OCGN)
(Delayed Data from NSDQ)
$0.99 USD
-0.04 (-3.53%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $0.99 0.00 (-0.36%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Ocugen, Inc. has a market cap of $300.79M, which represents its share price of $1.03 multiplied by its outstanding shares number of 292.03M. As a small-cap company, OCGN's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
OCGN 0.99 -0.04(-3.53%)
Will OCGN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for OCGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OCGN
Ocugen (OCGN) Reports Q2 Loss, Misses Revenue Estimates
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
OCGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Cooper Companies Q1 Earnings Likely to Reflect Seasonal Trends
5 Biotech Breakthrough Stocks to Watch in 2025
Ocugen (OCGN) Reports Q3 Loss, Misses Revenue Estimates
Other News for OCGN
Ocugen Inc (OCGN) Q2 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
Ocugen (OCGN) Advances Gene Therapy Initiatives Amidst Strategic Changes
Q2 2025 Ocugen Inc Earnings Call Transcript
Ocugen, Inc. (OCGN) Q2 2025 Earnings Call Transcript
Ocugen outlines three licensing applications and 2026 commercialization plans while advancing gene therapy trials